Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA PMA

Diagnostic low electric field

PMA Number: P110014 · 2025-09-17

ApplicantDilon Medical Technologies, Ltd.
Decision Date2025-09-17
PMA NumberP110014
Product CodeOEE
Device ClassClass 3
Medical SpecialtyU
Advisory CommitteeSU

Device Summary

Diagnostic low electric field is the device name listed in this FDA 510(k) record. The listed applicant is Dilon Medical Technologies, Ltd.. It received FDA 510(k) clearance on 2025-09-17. The device is classified under product code OEE. It was reviewed by the SU advisory panel.

Frequently Asked Questions

What is the Diagnostic low electric field?

Diagnostic low electric field is a medical device that received FDA 510(k) clearance on 2025-09-17. The listed applicant is Dilon Medical Technologies, Ltd..

When did Diagnostic low electric field receive FDA 510(k) clearance?

The clearance date for Diagnostic low electric field can be found in the official FDA records.

Who is the listed applicant for Diagnostic low electric field?

The FDA 510(k) record lists Dilon Medical Technologies, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Diagnostic low electric field?

The FDA product code for Diagnostic low electric field is OEE.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT04745156A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade GliomasNOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑